{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:40:15Z","timestamp":1790883615494,"version":"4.1.0"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2016,5,19]],"date-time":"2016-05-19T00:00:00Z","timestamp":1463616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Molise Region, Italy","award":["CUP H11J10000060002"],"award-info":[{"award-number":["CUP H11J10000060002"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0155694","type":"journal-article","created":{"date-parts":[[2016,5,20]],"date-time":"2016-05-20T05:24:37Z","timestamp":1463721877000},"page":"e0155694","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":106,"title":["Serum Levels of Acyl-Carnitines along the Continuum from Normal to Alzheimer's Dementia"],"prefix":"10.1371","volume":"11","author":[{"given":"Adriana","family":"Cristofano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Sapere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"La Marca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Angiolillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziamaria","family":"Corbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Scapagnini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Intrieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Corso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6138-5640","authenticated-orcid":false,"given":"Alfonso","family":"Di Costanzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,5,19]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"RC Petersen","year":"2004","journal-title":"J Intern Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1001\/jama.2014.13806","article-title":"The diagnosis and management of mild cognitive impairment: a clinical review","volume":"312","author":"KM Langa","year":"2014","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.eurpsy.2008.02.004","article-title":"Subjective Memory Impairment. A review of its definitions indicates the need for a comprehensive set of standardised and validated criteria","volume":"23","author":"K Abdulrab","year":"2008","journal-title":"Eur Psychiatry"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jalz.2014.11.006","article-title":"Subjective memory impairment in older adults predicts future dementia independent of baseline memory performance: Evidence from the Betula prospective cohort study","volume":"11","author":"M R\u00f6nnlund","year":"2015","journal-title":"Alzheimers Dement"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jagp.2014.07.009","article-title":"Hippocampal atrophy is associated with subjective memory decline: The PATH Through Life study","volume":"23","author":"N Cherbuin","year":"2015","journal-title":"Am J Geriatr Psychiatry"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1212\/WNL.0b013e31826c1a8d","article-title":"Glucose metabolism, gray matter structure, and memory decline in subjective memory impairment","volume":"79","author":"L Scheef","year":"2012","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1089\/brain.2013.0144","article-title":"Increased functional connectivity and brain atrophy in elderly with subjective memory complaints","volume":"3","author":"A Hafkemeijer","year":"2013","journal-title":"Brain Connect"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.plipres.2009.08.004","article-title":"Acylcarnitines: role in brain","volume":"49","author":"LL Jones","year":"2010","journal-title":"Prog Lipid Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-4580(95)80001-8","article-title":"Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer&apos;s disease","volume":"16","author":"JW Pettegrew","year":"1995","journal-title":"Neurobiol Aging"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1212\/WNL.41.11.1726","article-title":"Long-term acetyl-L carnitine treatment in Alzheimer&apos;s disease","volume":"41","author":"A Spagnoli","year":"1991","journal-title":"Neurology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1001\/archneur.1992.00530350051019","article-title":"Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer&apos;s disease","volume":"49","author":"M Sano","year":"1992","journal-title":"Arch Neurol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1212\/WNL.47.3.705","article-title":"A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer&apos;s disease","volume":"47","author":"LJ Thal","year":"1996","journal-title":"Neurology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1212\/WNL.55.6.805","article-title":"A 1-year controlled trial of acetyl-l-carnitine in early-onset AD","volume":"55","author":"LJ Thal","year":"2000","journal-title":"Neurology"},{"key":"ref14","first-page":"CD003158","article-title":"Acetyl-L-carnitine for dementia","author":"S Hudson","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"ref15","first-page":"15","article-title":"Mini Nutritional Assessment: A practical assessment tool for grading the nutritional state of elderly patients","volume":"2","author":"Y Guigoz","year":"1994","journal-title":"Facts Res Gerontol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer&apos;s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer&apos;s Disease","volume":"34","author":"G McKhann","year":"1984","journal-title":"Neurology"},{"key":"ref17","first-page":"189","article-title":"\u201cMinimental state\u201d: a practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"MF Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"ref18","first-page":"637","article-title":"Clinical Dementia Rating (CDR)","volume":"24","author":"L Berg","year":"1988","journal-title":"Psychopharmacol Bull"},{"key":"ref19","article-title":"L&apos;examen clinique en psychologie: Memorisation d&apos;une serie de 15 mots en 5 repetitions","author":"A Rey","year":"1958"},{"key":"ref20","first-page":"1","article-title":"Standardizzazione e taratura italiana di test neuropsicologici","volume":"8","author":"H Spinnler","year":"1987","journal-title":"Ital J Neurol Sci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1017\/S1041610292000991","article-title":"Assessment of memory complaint in age-associated memory impairment: the MAC-Q","volume":"4","author":"TH Crook 3rd","year":"1992","journal-title":"Int Psychogeriatr"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/(SICI)1099-1166(199910)14:10<858::AID-GPS35>3.0.CO;2-8","article-title":"Short versions of the geriatric depression scale: a study of their validity for the diagnosis of a major depressive episode according to ICD-10 and DSM-IV","volume":"14","author":"OP Almeida","year":"1999","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1038\/nutd.2013.33","article-title":"Children who develop type 1 diabetes early in life show low levels of carnitine and amino acids at birth: does this finding shed light on the etiopathogenesis of the disease?","volume":"3","author":"G la Marca","year":"2013","journal-title":"Nutr Diabetes"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1373\/clinchem.2009.131300","article-title":"National academy of clinical biochemistry laboratory medicine practice guidelines: follow-up testing for metabolic disease identified by expanded newborn screening using tandem mass spectrometry; executive summary","volume":"55","author":"DJ Dietzen","year":"2009","journal-title":"Clin Chem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-1-4939-3182-8_2","article-title":"Quantification of free carnitine and acylcarnitines in plasma or serum using HPLC\/MS\/MS","volume":"1378","author":"D Scott","year":"2016","journal-title":"Methods Mol Biol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/nar\/gks374","article-title":"MetaboAnalyst 2.0: a comprehensive server for metabolomic data analysis","volume":"4","author":"J Xia","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/nar\/gkp356","article-title":"MetaboAnalyst: a web server for metabolomic data analysis and interpretation","volume":"37","author":"J Xia","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nm.3466","article-title":"Plasma phospholipids identify antecedent memory impairment in older adults","volume":"20","author":"M Mapstone","year":"2014","journal-title":"Nat Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1002\/elps.201400196","article-title":"Metabolomic profiling of serum in the progression of Alzheimer&apos;s disease by capillary electrophoresis-mass spectrometry","volume":"35","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2014","journal-title":"Electrophoresis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0022-510X(97)00314-6","article-title":"Cerebrospinal fluid carnitine levels in patients with Alzheimer&apos;s disease","volume":"155","author":"JC Rubio","year":"1998","journal-title":"J Neurol Sci"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/BF01705539","article-title":"Carnitine, carnitine acetyltransferase, and glutathione in Alzheimer brain","volume":"20","author":"TK Makar","year":"1995","journal-title":"Neurochem Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jpba.2014.10.009","article-title":"Metabolomic screening of regional brain alterations in the APP\/PS1 transgenic model of Alzheimer&apos;s disease by direct infusion mass spectrometry","volume":"102","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2015","journal-title":"J Pharm Biomed Anal"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e105383","DOI":"10.1371\/journal.pone.0105383","article-title":"Integrating transcriptomics with metabolic modeling predicts biomarkers and drug targets for Alzheimer&apos;s disease","volume":"9","author":"S Stempler","year":"2014","journal-title":"PLoS One"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.biopha.2015.07.025","article-title":"Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight","volume":"74","author":"AH Bhat","year":"2015","journal-title":"Biomed Pharmacother"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0092-8674(02)01228-X","article-title":"Crystal structure of carnitine acetyltransferase and implications for the catalytic mechanism and fatty acid transport","volume":"112","author":"G Jogl","year":"2003","journal-title":"Cell"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1432-1033.1997.00001.x","article-title":"The mitochondrial carnitine palmitoyl-transferase system. From concept to molecular analysis","volume":"244","author":"JD McGarry","year":"1997","journal-title":"Eur J Biochem"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0167-4838(01)00147-9","article-title":"Molecular enzymology of carnitine transfer and transport","volume":"1546","author":"RR Ramsay","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev.bi.57.070188.001401","article-title":"Carnitine","volume":"57","author":"LL Bieber","year":"1988","journal-title":"Annu Rev Biochem"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/sj.mp.4000805","article-title":"Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer&apos;s disease and geriatric depression","volume":"5","author":"JW Pettegrew","year":"2000","journal-title":"Mol Psychiatry"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1586\/14737175.2013.814930","article-title":"Acetyl-L-carnitine: from a biological curiosity to a drug for the peripheral nervous system and beyond","volume":"13","author":"M Onofrj","year":"2013","journal-title":"Expert Rev Neurother"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.neuropharm.2013.08.022","article-title":"Acetyl-L-carnitine rescues scopolamine-induced memory deficits by restoring insulin-like growth factor II via decreasing p53 oxidation","volume":"76","author":"X Wang","year":"2014","journal-title":"Neuropharmacol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1042\/bj3220403","article-title":"Cloning and characterization of murine carnitine acetyltransferase: evidence for a requirement during cell cycle progression","volume":"322","author":"S Brunner","year":"1997","journal-title":"Biochem J"},{"key":"ref43","first-page":"76","article-title":"Acetyl-L-carnitine. Monograph","volume":"15","year":"2010","journal-title":"Altern Med Rev"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"e0119479","DOI":"10.1371\/journal.pone.0119479","article-title":"Acetyl-L-carnitine in the treatment of peripheral neuropathic pain: a systematic review and meta-analysis of randomized controlled trials","volume":"10","author":"S Li","year":"2015","journal-title":"PLoS One"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/ana.410320417","article-title":"Carnitine acetyltransferase activity in the human brain and its microvessels is decreased in Alzheimer&apos;s disease","volume":"32","author":"RN Kalaria","year":"1992","journal-title":"Ann Neurol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0304-3940(80)90220-7","article-title":"Coenzyme A-acetylating enzymes in Alzheimer&apos;s disease: possible cholinergic &apos;compartment&apos; of pyruvate dehydrogenase","volume":"18","author":"EK Perry","year":"1980","journal-title":"Neurosci Lett"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00002093-199806000-00003","article-title":"Carnitine acyltransferases are not changed in Alzheimer disease","volume":"12","author":"I Maurer","year":"1998","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1750-1326-8-33","article-title":"Current concepts in Alzheimer&apos;s Disease: molecules, models and translational perspectives","volume":"8","author":"BP Rutten","year":"2013","journal-title":"Mol Neurodegener"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"445","DOI":"10.31887\/DCNS.2013.15.4\/hjahn","article-title":"Memory loss in Alzheimer&apos;s disease","volume":"15","author":"H Jahn","year":"2013","journal-title":"Dialogues Clin Neurosci"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00004850-200303000-00001","article-title":"Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer&apos;s disease","volume":"18","author":"SA Montgomery","year":"2003","journal-title":"Int Clin Psychopharmacol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0155694","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T20:46:24Z","timestamp":1656449184000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0155694"}},"subtitle":[],"editor":[{"given":"Pradeep","family":"Garg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,5,19]]},"references-count":50,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,5,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0155694","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,19]]}}}